SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $27,942,000 | +36.8% | 2,540,200 | +21.9% | 0.04% | +24.1% |
| Q1 2017 | $20,424,000 | +6.8% | 2,084,100 | +17.8% | 0.03% | -3.3% |
| Q4 2016 | $19,115,000 | +34.7% | 1,769,898 | +27.8% | 0.03% | +20.0% |
| Q3 2016 | $14,196,000 | -6.4% | 1,385,000 | +19.2% | 0.02% | -13.8% |
| Q2 2016 | $15,172,000 | +47.9% | 1,161,700 | +24.6% | 0.03% | +52.6% |
| Q1 2016 | $10,255,000 | +91.2% | 932,300 | +59.9% | 0.02% | +58.3% |
| Q4 2015 | $5,364,000 | +74.3% | 583,080 | +31.5% | 0.01% | +71.4% |
| Q3 2015 | $3,078,000 | -54.7% | 443,500 | -35.9% | 0.01% | -53.3% |
| Q2 2015 | $6,792,000 | +74.1% | 691,660 | +57.1% | 0.02% | +87.5% |
| Q1 2015 | $3,902,000 | +123.4% | 440,400 | +120.8% | 0.01% | +100.0% |
| Q4 2014 | $1,747,000 | +195.1% | 199,420 | +132.2% | 0.00% | +100.0% |
| Q3 2014 | $592,000 | -65.0% | 85,900 | -73.3% | 0.00% | -50.0% |
| Q2 2014 | $1,690,000 | +41.2% | 321,326 | +22.2% | 0.00% | +33.3% |
| Q1 2014 | $1,197,000 | +1.1% | 263,007 | +12.0% | 0.00% | 0.0% |
| Q4 2013 | $1,184,000 | -53.9% | 234,904 | -53.6% | 0.00% | -50.0% |
| Q3 2013 | $2,566,000 | +280.7% | 506,100 | +272.7% | 0.01% | +200.0% |
| Q2 2013 | $674,000 | – | 135,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|